* to be confirmed
Ahti Anttila is Research Director of the Mass Screening Registry of the Finnish Cancer Registry. Principal investigator in the evaluation of the Finnish cervical and breast cancer screening programs at the Mass Screening Registry.
Marc Arbyn obtained his MD diploma in 1984 at the University of Ghent (Belgium); he obtained diplomas of Dr in tropical medicine and a MSc degree in tropical epidemiology at the Institute of Tropical Medicine in Antwerp.
Dr. Kevin Ault is a Professor and Division Director in the Department of Obstetrics and Gynecology at the University of Kansas Medical Center in Kansas City KS USA.
Dr. Johannes (Hans) Berkhof is head of the biostatistics unit of the VU University Medical Centre (VUMC) Amsterdam and has 15 years expertise in statistical and modelling research.
Professor Jacob Bornstein MD, MPA, is the Chairman of the Department of Obstetrics and Gynecology in Galilee Medical Center-Nahariya, Israel. He is Full Professor and Associate Dean at the Bar-Ilan University, Faculty of Medicine.
Xavier Bosch - Cancer epidemiologist and oncologist. Contributions to the research leading to the identification of the causal role of HPV in cervical cancer, international HPV type distributions in lesions and HPV impact on other cancers.
Dr. Bouchard is an Associate Clinical Professor in the Department of Obstetrics and Gynaecology at Laval University.
Ruud H. Brakenhoff, PhD is molecular biologist at the Tumor Biology section of the Department of Otolaryngology-Head and Neck Surgery of the VU University Medical Center, Amsterdam, the Netherlands.
Dr Marc Brisson is an associate professor at Laval University where he holds a Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Diseases.
Dr Julia Brotherton is a public health physician and Medical Director of Australia’s National HPV Vaccination Program Register.
Professor Karen Canfell is Director of the Cancer Research Division at Cancer Council NSW and Adjunct Professor at Sydney Medical School, University of Sydney. Karen holds a D.Phil. (PhD equivalent) in Epidemiology from the University of Oxford.
Francesca Maria Carozzi is Biologist. She has worked from 1989 at the Centro per lo Studio e la Prevenzione Oncologica of Florence in department of Molecular Unit.
Dr Gary Clifford, born in Brighton, UK in 1973, obtained his PhD in biological sciences at the University of Newcastle upon Tyne, UK.
Heather Cubie is a Consultant Clinical Scientist with an Honorary Chair in the University of Edinburgh College of Medicine and Veterinary Medicine.
Kate Cuschieri is a consultant clinical scientist in virology and Director of the Scottish HPV Reference Laboratory at the Royal Infirmary of Edinburgh, which has a remit that incorporates diagnostic testing, testing for population based surveillance and research.
Jack Cuzick is:
Director – Wolfson Institute of Preventive Medicine Head, CRUK Centre for Cancer Prevention
Tina Dalianis MD 1974, PhD 1980 Karolinska Institutet (KI), post doc 1987-1989 at NIMR, London, UK, became specialist in Clinical Virology 1991 and Clinical Immunology 1995 and was 1995-2000 head of the Section of Transplantation Immunology, Huddinge Hospital.
Dr. Silvia de Sanjosé received her Medical degree (University of Barcelona, Spain 1980); Specialized in Family practice (University of Barcelona, Spain 1983); Master of Science in Epidemiology (London School of Hygiene and Tropical Medicine, University of London (1986);
Joakim Dillner is professor in infectious disease epidemiology at Karolinska Institutet. His research is focused on cancer screening and tumor virology, especially human papillomavirus (HPV).
Gypsyamber D’Souza is an associate professor Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She studies oral, anal, and cervical HPV epidemiology.
Mark H. Einstein, MD, MS, FACOG, FACS Professor and Vice Chair for Research, Department of Obstetrics & Gynecology and Women’s Health at the Albert Einstein College of Medicine and Montefiore Medical Center.
Miriam Elfström’s background is in public health and she is currently working at the Karolinska Institute in Stockholm, Sweden.
Dr. Carole Fakhry is a head and neck oncologic surgeon with a research focus in HPV and head and neck cancer.
Dr Silvia Franceschi, Special Advisor and Head, Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France:
Dr. Franco is Professor and Chair, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal, Canada.
Professor Suzanne Garland is an internationally recognized clinical microbiologist and sexual health physician, with particular expertise in infectious diseases as they pertain to reproductive health and the neonate.
Dr. Anna Giuliano is the founding Director of the Center for Infection Research in Cancer (CIRC) at the Moffitt Cancer Center and is an expert in this field with a long and successful record of NIH funding.
Dr. Goodman’s research focus is on the natural history of human papillomavirus-related anogenital disease and the identification of cofactors in viral persistence;
Dr. Gravitt is a molecular epidemiologist whose research in human papillomavirus and cervical cancer spans the translational spectrum from natural history to global cervical prevention.
Dr Harper is Rowntree Endowed Professor and Chair of Family and Geriatric Medicine at the University of Louisville.
Danielle A.M. Heideman gained her MSc degree in Medical Biology cum laude in 1998, and holds a PhD degree from VU University Amsterdam, the Netherlands.
Professor Thomas Iftner graduated in Biology/Virology and did his postgraduate research fellowship at the University of California, Los Angeles.
Mark Jit is senior scientist in the Modelling and Economics Unit of Public Health England (PHE) and senior lecturer in vaccine epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM).
Elmar A. Joura, M.D., is Associate Professor of Gynecology and Obstetrics at the Medical University of Vienna, General Hospital (AKH), and Comprehensive Cancer Center Vienna, Austria.
Dr. Kaufmann holds a position as head of research at the Clinic for Gynaecology of the Charité-Universitätsmedizin Berlin, Germany.
Walter Kinney is a Gyn Oncologist who is also Board Certified in Internal Medicine, and practices in The Permanente Medical Group.
Aimée R. Kreimer is an Investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute (NCI) and focuses her research on the etiology and prevention of humanpapillomavirus associated cancers of the head and neck and anogenital sites.
Dr. Kulasingam is an Associate Professor in the Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Twin Cities.
Dr Maria Kyrgiou is an Academic Gynaecologist and Gynaecologic Oncology surgeon working at Imperial College London.
Lisa Licitra is Board-certified in medical oncology, with special expertise in the treatment of head and neck cancers..
Pier Luigi Lopalco, MD, Professor of Hygiene and Preventive Medicine at the University of Bari (Italy). In 2005 he joined the ECDC, where is Head of the Scientific Assessment Section.
Attila Lorincz discovered and cloned several important and novel carcinogenic HPV types, including HPV31, HPV35, HPV45, HPV52 and HPV56, and pioneered the initial use of HPV DNA testing for clinical diagnostics.
Chris Meijer is MD (Leiden 1972), PhD (Amsterdam 1971), and surgical pathologist (Leiden, since 1977) with a strong interest in immunology and molecular biology.
Lisa Mirabello is a genetic epidemiologist whose research is focused on understanding the viral genetic basis of HPV carcinogenesis. She is a principal investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute (NCI).
Haïtham Mirghani is a head and neck surgeon at the Gustave Roussy Cancer Center in Paris with a strong interest in HPV-driven head and neck cancers.
Dr. Moscicki is currently Professor of Pediatrics at UCSF, Associate Director, Division of Adolescent Medicine and Vice-Chair Department of Pediatrics, Clinical and Translation Research.
Alan G. Nyitray is an assistant professor studying HPV in men with a focus on the natural history of anal HPV infection and anal cancer.
Mario Poljak, MD, PhD, specialist in clinical microbiology is Professor of Microbiology and Immunology and Head of Laboratory for Molecular Microbiology
You-lin Qiao, MD, PhD, professor and Director for Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.
Dr. Wim Quint is founder of DDL Diagnostic Laboratory and working in the field of HPV since 1987.
MD. , Clinical Lecturer - Rappaport Faculty of Medicine Technion, Haifa, Israel Head of Cervical Clinic – Clalit Health Organization Haifa District and Carmel Medical Center. Past President and present Secretary of the Israeli Society of Colposcopy and Cervical Pathology.
Professor Albert Singer
Academic and clinical interest in the cervix and lower genital tract for many years .
Jennifer S. Smith is an Associate Professor in the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina.
Dr. Peter Snijders gained his degree in biology in 1987 from the Catholic University in Nijmegen. He holds a doctoral degree in Medicine from VU University in Amsterdam.
A family practitioner, Dr Steben is medical advisor at the STI unit of Quebec’s National Public Health Institute. He chairs Québec province committee on STI and member of the STI laboratory analysis committee.
Professor Stanley is Professor of Epithelial Biology and Director of Research in the University of Cambridge Honorary Consultant Addenbrookes Hospital Cambridge and Fellow of Christs College.
Professor Peter L Stern is at the Institute of Cancer Studies, Paterson Building, University of Manchester, UK. He trained at University College, London, UK, obtaining his BSc and PhD.
Dr. Mark H. Stoler is Professor (Emeritus) of Pathology and Clinical Gynecology at the University of Virginia Health System, Charlottesville.
Kari Syrjänen (Chief Medical Director, BIOHIT HealthCare Plc, Helsinki, Finland) is one of the pioneers in HPV research, with over 840 published papers.
Sjoerd H. van der Burg, Ph.D. is a professor in the immunotherapy of cancer, with a special emphasis on immunomonitoring at the department of clinical oncology of the Leiden University Medical Center
Magnus von Knebel Doeberitz is Professor of Molecular Oncology and Medical Director of the Department of Applied Tumor Biology, Institute of Pathology of the University of Heidelberg.
Tim Waterboer, PhD MSc is head of the Infection and Cancer Epidemiology Group at the German Cancer Research Center (DKFZ) in Heidelberg.
Nicolas Wentzensen M.D., Ph.D., M.S. is a Senior Investigator and Deputy Branch Chief at the Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Dr. Zimet is Professor of Pediatrics and Clinical Psychology at Indiana University School of Medicine, Indianapolis, IN, USA. His research focuses on behavioral and social science related to HPV vaccination and cervical cancer screening.
AMSTERDAM - OCTOBER 8, 2017
From Control to Eradication of HPV infection and related diseases
Call for action
Welcome by the Chairman of the Scientific Committee (Joseph Monsonego) and by the Congress Presidents (Joakim Dillner, Peter Snijders)
2. Is the elimination of HPV infection and related diseases possible?
A. Giuliano – 15 minutes
European Parliament, a point of view (title to be confirmed)
K. Kadenbach (tbc.) – 15 minutes
Towards better cooperation between science and health authorities
Round table with representatives from both sides (science / health authorities)
Silvia Franceschi, Silvia De Sanjosé, Margaret Stanley,
Karin Kadenbach (European Parliament, tbd.)
Nynke Van der Veen (Program Manager Cervical Cancer Screening in The Netherlands)
Agenda for the Elimination of HPV related diseases
Call for action by the EUROGIN Scientific Committee (declaration of commitment)
Long-term tracking of HPV related diseases
The committee will issue a report each year:
- How far have we come: situation by regions / countries
- How far do we need to go / what should be the next steps?
Coordinator: X. Bosch
Close, followed by Welcome Reception